HAWTHORNE, N.Y.--(BUSINESS WIRE)--Aug. 29, 2006--Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” NASDAQ: TARO) today provided an update on the Company’s progress in filing its Annual Report on Form 20-F for the year ended December 31, 2005 (the “2005 Form 20-F”) with the Securities and Exchange Commission. Previously, the Company had stated that it expected to file the 2005 Form 20-F in August.
